Skip Navigation


Human Molecular Genetics Advance Access originally published online on July 6, 2004
Human Molecular Genetics 2004 13(17):1951-1958; doi:10.1093/hmg/ddh201
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
13/17/1951    most recent
ddh201v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (15)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Engelmark, M.
Right arrow Articles by Gyllensten, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Engelmark, M.
Right arrow Articles by Gyllensten, U.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, Vol. 13, No. 17 © Oxford University Press 2004; all rights reserved

Affected sib-pair analysis of the contribution of HLA class I and class II loci to development of cervical cancer

Malin Engelmark1, Anna Beskow1, Jessica Magnusson1, Henry Erlich2 and Ulf Gyllensten1,*

1Department of Genetics and Pathology, Section of Medical Genetics, Rudbeck Laboratory, University of Uppsala, S-751 85 Uppsala, Sweden and 2Roche Molecular Systems, Berkeley, CA, USA

Received March 29, 2004; Accepted June 22, 2004

Cervical cancer is a multifactorial disease and infection by oncogenic human papilloma viruses represents the main environmental risk factor. Only a subset of infections becomes persistent and develops into cancer, implying that genetic susceptibility factors are needed for malignant progression. Here, we use a population-based cohort of affected sib-pairs (ASPs) to examine the role of the human leukocyte antigen (HLA) class I and class II loci in cervical cancer susceptibility. Analysis of 278 ASPs revealed significant excess genetic sharing for all three HLA class II loci studied, DPB1, DQB1 and DRB1, with the strongest evidence for DQB1 and DRB1. No evidence of excess sharing was observed for the HLA class I HLA-B and HLA-A loci. When the material was stratified on the basis of the DQB1*0602/DRB1*1501 susceptibility haplotype, carriers showed significant sharing for all loci, whereas non-carriers showed no evidence of excess genetic sharing at any of the loci. However, for the DPB1 locus there was no difference in allele frequency between carriers and non-carriers indicating that the effect seen in DPB1 is not simply due to linkage disequilibrium. Our results show that the HLA class II represents a major genetic susceptibility locus to cervical cancer in contrary to the class I that do not appear to have a significant impact on predisposition to the disease. The strongest class II effects are coming from the DQB1 and DRB1 loci, but the DPB1 locus also contributes to the susceptibility to cervical cancer.

* To whom correspondence should be addressed. Tel: +46 184714909; Fax: +46 184714931; Email: ulf.gyllensten{at}genpat.uu.se


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 IOVSHome page
M. Abbas, L. D. Bobo, Y.-H. Hsieh, N. Berka, G. Dunston, G. E. Bonney, V. Apprey, T. C. Quinn, and S. K. West
Human Leukocyte Antigen (HLA)-B, DRB1, and DQB1 Allotypes Associated with Disease and Protection of Trachoma Endemic Villagers
Invest. Ophthalmol. Vis. Sci., April 1, 2009; 50(4): 1734 - 1738.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
V. B. Guzman, A. Yambartsev, A. Goncalves-Primo, I. D.C.G. Silva, C. R.N. Carvalho, J. C.L. Ribalta, L. R. Goulart, N. Shulzhenko, M. Gerbase-DeLima, and A. Morgun
New approach reveals CD28 and IFNG gene interaction in the susceptibility to cervical cancer
Hum. Mol. Genet., June 15, 2008; 17(12): 1838 - 1844.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. M. Madeleine, L. G. Johnson, A. G. Smith, J. A. Hansen, B. B. Nisperos, S. Li, L.-P. Zhao, J. R. Daling, S. M. Schwartz, and D. A. Galloway
Comprehensive Analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 Loci and Squamous Cell Cervical Cancer Risk
Cancer Res., May 1, 2008; 68(9): 3532 - 3539.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
M. T. Engelmark, E. L. Ivansson, J. J. Magnusson, I. M. Gustavsson, A. H. Beskow, P. K.E. Magnusson, and U. B. Gyllensten
Identification of susceptibility loci for cervical carcinoma by genome scan of affected sib-pairs
Hum. Mol. Genet., November 15, 2006; 15(22): 3351 - 3360.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
M Zoodsma, I M Nolte, M Schipper, E Oosterom, G van der Steege, E G E de Vries, G J te Meerman, and A G J van der Zee
Analysis of the entire HLA region in susceptibility for cervical cancer: a comprehensive study
J. Med. Genet., August 1, 2005; 42(8): e49 - e49.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.